Skip to main content

Advertisement

Log in

Role of broncho: alveolar lavage in approaching interstitial lung diseases

  • Interstitial Lung Disease (E Alhamed, Section Editor)
  • Published:
Current Pulmonology Reports Aims and scope Submit manuscript

Abstract

Bronchoalveolar lavage (BAL) is a simple and safe procedure performed during flexible bronchoscopy. BAL provides an important diagnostic tool in the diagnosis of various diffuse lung diseases. BAL fluid analysis for cell count and differential, bacteriology and cytology may suggest specific disease or give alternative diagnosis. Nevertheless, BAL is seldom useful as a “stand-alone” diagnostic test for various diffuse pulmonary diseases. Confident diagnoses can be obtained when clinical evaluation and high-resolution computed tomography of the chest (HRCT) findings are combined with BAL fluid analysis and/or transbronchial lung biopsy. BAL may also be helpful in determining the response to treatment and prognosis of interstitial pulmonary disease. This review is about the role of BAL in approaching patients with interstitial lung diseases (ILDs) and will describe the value of different cell patterns found.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Kilinc G, Kolsuk EA. The role of bronchoalveolar lavage in diffuse parenchymal lung diseases. Curr Opin Pulm Med. 2005;11(5):417–21.

    Article  PubMed  Google Scholar 

  2. American Thoracic S, European RS. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med. 2002;165(2):277–304.

    Article  Google Scholar 

  3. Meyer KC, Raghu G, Baughman RP, Brown KK, Costabel U, du Bois RM, et al. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med. 2012;185(9):1004–14. This is ATS guideline written by experts in the interstitial pulmonary disease. Very comprehensive explain the findings of BAL in ILD also discuses other aspect of technical aspect of BAL procedures. It is very essential for all pulmonologist to read.

    Article  PubMed  Google Scholar 

  4. Report of the European Society of Pneumology Task Group on BAL. Clinical guidelines and indications for bronchoalveolar lavage (BAL). Eur Respir J. 1990;3(8):937–76.

    Google Scholar 

  5. Kanne JP. Interstitial lung disease (ILD): imaging finding, and the role of imaging in evaluating the patient with known or suspected ILD. Semin Roentgenol. 2010;45(1):3.

    Article  PubMed  Google Scholar 

  6. Credle Jr WF, Smiddy JF, Elliott RC. Complications of fiberoptic bronchoscopy. Am Rev Respir Dis. 1974;109(1):67–72.

    PubMed  Google Scholar 

  7. Costabel U, Guzman J. Bronchoalveolar lavage in interstitial lung disease. Curr Opin Pulm Med. 2001;7(5):255–61.

    Article  CAS  PubMed  Google Scholar 

  8. Baughman RP. Technical aspects of bronchoalveolar lavage: recommendations for a standard procedure. Semin Respir Crit Care Med. 2007;28(5):475–85. This review article is very important, it summarizes all previous the recommendations and discusses the variable effects they have on BAL results it also provide a standard methodology that can be used by the largest number of pulmonologists.

    Article  PubMed  Google Scholar 

  9. Martin TR, Raghu G, Maunder RJ, Springmeyer SC. The effects of chronic bronchitis and chronic air-flow obstruction on lung cell populations recovered by bronchoalveolar lavage. Am Rev Respir Dis. 1985;132(2):254–60.

    CAS  PubMed  Google Scholar 

  10. The BAL Cooperative Group Steering Committee. Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. Am Rev Respir Dis. 1990;141((5 Pt 2):S169–202.

    Google Scholar 

  11. Meyer KC. Bronchoalveolar lavage as a diagnostic tool. Semin Respir Crit Care Med. 2007;28(5):546–60.

    Article  PubMed  Google Scholar 

  12. Reynolds HY. Use of bronchoalveolar lavage in humans—past necessity and future imperative. Lung. 2000;178(5):271–93.

    Article  CAS  PubMed  Google Scholar 

  13. Meyer KC, Raghu G. Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful? Eur Respir J. 2011;38(4):761–9. This is a Very useful review of how to use BAL as a diagnostic tool for the diagnosis of ILD it mentioned briefly the therapeutic role of BAL but not in details. It is short and up to the point.

    Article  CAS  PubMed  Google Scholar 

  14. Welker L, Jorres RA, Costabel U, Magnussen H. Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases. Eur Respir J. 2004;24(6):1000–6.

    Article  CAS  PubMed  Google Scholar 

  15. Domagala-Kulawik J, Skirecki T, Maskey-Warzechowska M, Grubek-Jaworska H, Chazan R. Bronchoalveolar lavage total cell count in interstitial lung diseases—does it matter? Inflammation. 2012;35(3):803–9.

    Article  PubMed  Google Scholar 

  16. Daniele RP, Elias JA, Epstein PE, Rossman MD. Bronchoalveolar lavage: role in the pathogenesis, diagnosis, and management of interstitial lung disease. Ann Intern Med. 1985;102(1):93–108.

    Article  CAS  PubMed  Google Scholar 

  17. Kantrow SP, Meyer KC, Kidd P, Raghu G. The CD4/CD8 ratio in BAL fluid is highly variable in sarcoidosis. Eur Respir J. 1997;10(12):2716–21.

    Article  CAS  PubMed  Google Scholar 

  18. Drent M, van Nierop MA, Gerritsen FA, Wouters EF, Mulder PG. A computer program using BALF-analysis results as a diagnostic tool in interstitial lung diseases. Am J Respir Crit Care Med. 1996;153(2):736–41.

    Article  CAS  PubMed  Google Scholar 

  19. Schnabel A, Richter C, Bauerfeind S, Gross WL. Bronchoalveolar lavage cell profile in methotrexate induced pneumonitis. Thorax. 1997;52(4):377–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Laviolette M, Cormier Y, Loiseau A, Soler P, Leblanc P, Hance AJ. Bronchoalveolar mast cells in normal farmers and subjects with farmer’s lung. Diagnostic, prognostic, and physiologic significance. Am Rev Respir Dis. 1991;144(4):855–60.

    Article  CAS  PubMed  Google Scholar 

  21. Nagai S, Kitaichi M, Itoh H, Nishimura K, Izumi T, Colby TV. Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur Respir J. 1998;12(5):1010–9.

    Article  CAS  PubMed  Google Scholar 

  22. Meyer KC. The role of bronchoalveolar lavage in interstitial lung disease. Clin Chest Med. 2004;25(4):637–49.

    Article  PubMed  Google Scholar 

  23. Bradley B, Branley HM, Egan JJ, Greaves MS, Hansell DM, Harrison NK, et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax. 2008;63(5):v1–v58.

    PubMed  Google Scholar 

  24. Pesci A, Bertorelli G, Manganelli P, Mori PA, Strinati F, Marangio E, et al. Bronchoalveolar lavage in chronic eosinophilic pneumonia. Analysis of six cases in comparison with other interstitial lung diseases. Respiration. 1988;54(1):16–22.

    Article  PubMed  Google Scholar 

  25. Hesselstrand R, Wildt M, Bozovic G, Andersson-Sjoland A, Andreasson K, Scheja A, et al. Biomarkers from bronchoalveolar lavage fluid in systemic sclerosis patients with interstitial lung disease relate to severity of lung fibrosis. Respir Med. 2013;107(7):1079–86.

    Article  PubMed  Google Scholar 

  26. Lee W, Chung WS, Hong KS, Huh J. Clinical usefulness of bronchoalveolar lavage cellular analysis and lymphocyte subsets in diffuse interstitial lung diseases. Ann Lab Med. 2015;35(2):220–5. This study examine usufulness of lymphocytes subset of BAL analysis in the dignaosis of diffuse interstitial pneumonia. It concluse that examining lymphocyes subset is not benficial except for sarcoidosis and eosinphilic pneumonia.

    Article  PubMed Central  PubMed  Google Scholar 

  27. Flaherty KR, King Jr TE, Raghu G, Lynch 3rd JP, Colby TV, Travis WD, et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med. 2004;170(8):904–10. Mutidisciplinary approach for Idiopathic interstitial pneumonia is very crucial. This study is about the effect of a multidisciplinary approach to diagnosis of Idiopathic interstitial pneumonia. It conclude that dynamic interactions between clinicians, radiologists, and pathologists improve interobserver agreement and diagnostic confidence.

    Article  PubMed  Google Scholar 

  28. Veeraraghavan S, Latsi PI, Wells AU, Pantelidis P, Nicholson AG, Colby TV, et al. BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia. Eur Respir J. 2003;22(2):239–44.

    Article  CAS  PubMed  Google Scholar 

  29. Przybylski G, Chorostowska-Wynimko J, Dyczek A, Wedrowska E, Jankowski M, Szpechcinski A, et al. Studies of hepatocyte growth factor (HGF) in bronchoalveolar lavage (BAL) in chronic interstitial lung diseases (ILDs). Pol Arch Med Wewn. 2015

  30. Ryu YJ, Chung MP, Han J, Kim TS, Lee KS, Chun EM, et al. Bronchoalveolar lavage in fibrotic idiopathic interstitial pneumonias. Respir Med. 2007;101(3):655–60.

    Article  PubMed  Google Scholar 

  31. Lynch DA, Rose CS, Way D, King Jr TE. Hypersensitivity pneumonitis: sensitivity of high-resolution CT in a population-based study. AJR Am J Roentgenol. 1992;159(3):469–72.

    Article  CAS  PubMed  Google Scholar 

  32. Hauber HP, Zabel P. PAS staining of bronchoalveolar lavage cells for differential diagnosis of interstitial lung disease. Diagn Pathol. 2009;4:13.

    Article  PubMed Central  PubMed  Google Scholar 

  33. Drent M, van Velzen-Blad H, Diamant M, Wagenaar SS, Donckerwolck-Bogaert M, van den Bosch JM. Differential diagnostic value of plasma cells in bronchoalveolar lavage fluid. Chest. 1993;103(6):1720–4.

    Article  CAS  PubMed  Google Scholar 

  34. Pesci A, Bertorelli G, Gabrielli M, Olivieri D. Mast cells in fibrotic lung disorders. Chest. 1993;103(4):989–96.

    Article  CAS  PubMed  Google Scholar 

  35. Garcia JG, James HL, Zinkgraf S, Perlman MB, Keogh BA. Lower respiratory tract abnormalities in rheumatoid interstitial lung disease. Potential role of neutrophils in lung injury. Am Rev Respir Dis. 1987;136(4):811–7.

    Article  CAS  PubMed  Google Scholar 

  36. Komocsi A, Kumanovics G, Zibotics H, Czirjak L. Alveolitis may persist during treatment that sufficiently controls muscle inflammation in myositis. Rheumatol Int. 2001;20(3):113–8.

    Article  CAS  PubMed  Google Scholar 

  37. Ramirez P, Valencia M, Torres A. Bronchoalveolar lavage to diagnose respiratory infections. Semin Respir Crit Care Med. 2007;28(5):525–33.

    Article  PubMed  Google Scholar 

  38. Fujisawa T, Suda T, Nakamura Y, Enomoto N, Ide K, Toyoshima M, et al. Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis. J Rheumatol. 2005;32(1):58–64.

    PubMed  Google Scholar 

  39. Kowal-Bielecka O, Kowal K, Highland KB, Silver RM. Bronchoalveolar lavage fluid in scleroderma interstitial lung disease: technical aspects and clinical correlations: review of the literature. Semin Arthritis Rheum. 2010;40(1):73–88.

    Article  PubMed  Google Scholar 

  40. De Santis M, Bosello SL, Peluso G, Pinnelli M, Alivernini S, Zizzo G, et al. Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease. Clin Respir J. 2012;6(1):9–17.

    Article  PubMed  Google Scholar 

  41. Silver RM, Metcalf JF, Stanley JH, LeRoy EC. Interstitial lung disease in scleroderma. Analysis by bronchoalveolar lavage. Arthritis Rheum. 1984;27(11):1254–62.

    Article  CAS  PubMed  Google Scholar 

  42. Behr J, Vogelmeier C, Beinert T, Meurer M, Krombach F, Konig G, et al. Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung. Am J Respir Crit Care Med. 1996;154(2 Pt 1):400–6.

    Article  CAS  PubMed  Google Scholar 

  43. Drent M, Mansour K, Linssen C. Bronchoalveolar lavage in sarcoidosis. Semin Respir Crit Care Med. 2007;28(5):486–95.

    Article  PubMed  Google Scholar 

  44. Danila E, Norkuniene J, Jurgauskiene L, Malickaite R. Diagnostic role of BAL fluid CD4/CD8 ratio in different radiographic and clinical forms of pulmonary sarcoidosis. Clin Respir J. 2009;3(4):214–21.

    Article  PubMed  Google Scholar 

  45. Kolopp-Sarda MN, Kohler C, De March AK, Bene MC, Faure G. Discriminative immunophenotype of bronchoalveolar lavage CD4 lymphocytes in sarcoidosis. Lab Investig. 2000;80(7):1065–9.

    Article  CAS  PubMed  Google Scholar 

  46. Vahid B, Marik PE. Pulmonary complications of novel antineoplastic agents for solid tumors. Chest. 2008;133(2):528–38.

    Article  CAS  PubMed  Google Scholar 

  47. Costabel U, Uzaslan E, Guzman J. Bronchoalveolar lavage in drug-induced lung disease. Clin Chest Med. 2004;25(1):25–35.

    Article  PubMed  Google Scholar 

  48. Akoun GM, Cadranel JL, Rosenow EC, Milleron BJ. Bronchoalveolar lavage cell data in drug-induced pneumonitis. Allergy Immunol. 1991;23(6):245–52.

    CAS  Google Scholar 

  49. Costabel U, Guzman J, Bonella F, Oshimo S. Bronchoalveolar lavage in other interstitial lung diseases. Semin Respir Crit Care Med. 2007;28(5):514–24.

    Article  PubMed  Google Scholar 

  50. Gupta S, Smith P, Twigg Iii HL, Hage CA. Bronchoalveolar lavage cellular patterns in monoclonal antibody-induced lung disease. Respiration. 2014;88(3):185–9.

    Article  CAS  PubMed  Google Scholar 

  51. Sherman JM, Winnie G, Thomassen MJ, Abdul-Karim FW, Boat TF. Time course of hemosiderin production and clearance by human pulmonary macrophages. Chest. 1984;86(3):409–11.

    Article  CAS  PubMed  Google Scholar 

  52. Corwin RW, Irwin RS. The lipid-laden alveolar macrophage as a marker of aspiration in parenchymal lung disease. Am Rev Respir Dis. 1985;132(3):576–81.

    CAS  PubMed  Google Scholar 

  53. Lauque D, Dongay G, Levade T, Caratero C, Carles P. Bronchoalveolar lavage in liquid paraffin pneumonitis. Chest. 1990;98(5):1149–55.

    Article  CAS  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflicts of Interest

The authors declare that they have no conflicts of interests related to the material.

Human and Animal Rights and Informed Consent

This article contains no studies with human or animal subjects performed by the author.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hamdan AL-Jahdali.

Additional information

This article is part of the Topical Collection on Interstitial Lung Disease

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Khan, M., Sherbini, N. & AL-Jahdali, H. Role of broncho: alveolar lavage in approaching interstitial lung diseases. Curr Pulmonol Rep 4, 117–124 (2015). https://doi.org/10.1007/s13665-015-0122-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13665-015-0122-8

Keywords

Navigation